Brokerages expect Envision Healthcare Corporation (NYSE:EVHC) to post sales of $2.00 billion for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Envision Healthcare Corporation’s earnings. The lowest sales estimate is $1.94 billion and the highest is $2.06 billion. Envision Healthcare Corporation reported sales of $822.22 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 143.2%. The firm is scheduled to announce its next earnings results on Tuesday, November 7th.

According to Zacks, analysts expect that Envision Healthcare Corporation will report full-year sales of $2.00 billion for the current year, with estimates ranging from $7.78 billion to $8.01 billion. For the next year, analysts expect that the company will post sales of $8.73 billion per share, with estimates ranging from $8.28 billion to $9.06 billion. Zacks’ sales calculations are an average based on a survey of research firms that cover Envision Healthcare Corporation.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same period in the prior year, the company posted $0.34 EPS. The business’s revenue for the quarter was up 156.7% on a year-over-year basis.

Several research analysts recently commented on EVHC shares. Bank of America Corporation reduced their price target on Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday. Jefferies Group LLC set a $71.00 price target on Envision Healthcare Corporation and gave the company a “buy” rating in a research report on Thursday, August 24th. Cantor Fitzgerald reissued a “buy” rating and set a $80.00 price target on shares of Envision Healthcare Corporation in a research report on Tuesday, July 4th. Zacks Investment Research raised Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price target for the company in a research report on Tuesday, July 4th. Finally, BidaskClub raised Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $75.33.

Envision Healthcare Corporation (NYSE EVHC) traded down 1.27% during trading on Wednesday, hitting $41.84. 2,164,946 shares of the stock were exchanged. The company’s market cap is $4.90 billion. Envision Healthcare Corporation has a one year low of $41.57 and a one year high of $74.75. The stock’s 50 day moving average is $47.48 and its 200-day moving average is $55.16.

Envision Healthcare Corporation announced that its board has initiated a share buyback plan on Monday, September 18th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to repurchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/11/2-00-billion-in-sales-expected-for-envision-healthcare-corporation-evhc-this-quarter-3.html.

Several institutional investors and hedge funds have recently added to or reduced their stakes in EVHC. BlackRock Inc. lifted its position in shares of Envision Healthcare Corporation by 3,895.0% in the first quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after buying an additional 7,017,467 shares during the last quarter. Janus Henderson Group PLC lifted its position in shares of Envision Healthcare Corporation by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after buying an additional 3,934,185 shares during the last quarter. Maverick Capital Ltd. lifted its position in shares of Envision Healthcare Corporation by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after buying an additional 2,028,026 shares during the last quarter. Janus Capital Management LLC lifted its position in shares of Envision Healthcare Corporation by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock valued at $167,536,000 after buying an additional 1,055,014 shares during the last quarter. Finally, Lord Abbett & CO. LLC lifted its position in shares of Envision Healthcare Corporation by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock valued at $82,808,000 after buying an additional 953,928 shares during the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Get a free copy of the Zacks research report on Envision Healthcare Corporation (EVHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.